This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
MHC class I-restricted cytotoxic T-lymphocytes (CTL) play an important role in controlling human immunodeficiency virus and simian immunodeficiency virus (SIV) infection. As a natural host of SIV, sooty mangabeys (Cercocebus atys; Ceat) are a valuable model for the study of AIDS pathogenesis.
We have previously defined several immunodominant SIV-specific CTL epitopes in sooty mangabeys and shown that CD8+ T lymphocytes inhibit SIV replication in vivo in naturally SIV-infected sooty mangabeys. In order to identify the MHC class I restriction of immunodominant CTL epitopes, we have cloned and characterized MHC class I genes of sooty mangabeys. cDNA libraries generated from two naturally SIV-infected sooty mangabeys were screened for MHC Class I cDNA with an oligonucleotide probe which hybridizes to a conserved region in exon 4 of primate MHC Class I genes.
Based on a minimum of two clones with identical full-length MHC class I sequence, to date we have identified five MHC-A locus alleles designated as Ceat-A*0101 to Ceat-A*0501, and 12 MHC-B locus alleles designated as Ceat-B*0101 to Ceat-B*1201 in sooty mangabeys. Sequence specific primers (SSP) have been developed for the defined MHC class I alleles to enable large-scale MHC Class I typing of sooty mangabey genomic DNA by PCR-SSP. MHC genotyping of the colony of SIV-infected and SIV-negative sooty mangabeys at YNPRC is in progress.
Public Health Relevance Statement
Data not available.
NIH Spending Category
GeneticsHIV/AIDS
Project Terms
Acquired Immunodeficiency SyndromeAllelesCD8-Positive T-LymphocytesCercocebus atysComplementary DNAComputer Retrieval of Information on Scientific Projects DatabaseCytotoxic T-LymphocytesDNAExonsFundingGenomicsGenotypeGrantHIVInstitutionLengthMHC Class I GenesOligonucleotide ProbesPathogenesisPlayPrimatesResearchResearch PersonnelResourcesRoleSIVSourceStudy modelsT-Lymphocyte EpitopesUnited States National Institutes of HealthViralVirus DiseasesVirus ReplicationbasecDNA Libraryin vivo
No Sub Projects information available for 5P51RR000165-50 8313
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P51RR000165-50 8313
Patents
No Patents information available for 5P51RR000165-50 8313
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P51RR000165-50 8313
Clinical Studies
No Clinical Studies information available for 5P51RR000165-50 8313
News and More
Related News Releases
No news release information available for 5P51RR000165-50 8313
History
No Historical information available for 5P51RR000165-50 8313
Similar Projects
No Similar Projects information available for 5P51RR000165-50 8313